Financhill
Back

Arcturus Therapeutics Holdings Stock Price Chart

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!
Sell
38

ARCT
Arcturus Therapeutics Holdings

Last Price:
18.25
Seasonality Move:
9.45%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARCT is experiencing slight selling pressure.

Arcturus Therapeutics Holdings Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 18.42 Sell
20-day SMA: 19.68 Sell
50-day SMA: 20.68 Sell
200-day SMA: 27.62 Sell
8-day EMA: 18.5 Sell
20-day EMA: 19.5 Sell
50-day EMA: 20.7 Sell
200-day EMA: 24.74 Sell

Arcturus Therapeutics Holdings Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.95 Sell
Relative Strength Index (14 RSI): 38.3 Sell
Chaikin Money Flow: -183326 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.41 - 22.73) Sell
Bollinger Bands (100): (19.25 - 24.25) Sell

Arcturus Therapeutics Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Arcturus Therapeutics Holdings Stock

Is Arcturus Therapeutics Holdings Stock a Buy?

ARCT Technical Analysis vs Fundamental Analysis

Sell
38
Arcturus Therapeutics Holdings (ARCT) is a Sell

Is Arcturus Therapeutics Holdings a Buy or a Sell?

Arcturus Therapeutics Holdings Stock Info

Market Cap:
495.68M
Price in USD:
18.33
Share Volume:
777.9K

Arcturus Therapeutics Holdings 52-Week Range

52-Week High:
45.00
52-Week Low:
17.26
Sell
38
Arcturus Therapeutics Holdings (ARCT) is a Sell

Arcturus Therapeutics Holdings Share Price Forecast

Is Arcturus Therapeutics Holdings Stock a Buy?

Fundamental Analysis of Arcturus Therapeutics Holdings

Is Arcturus Therapeutics Holdings a good investment?

  • Analysts estimate an earnings decrease this quarter of $1.49 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and an increase next year of $1.47 per share.

Technical Analysis of Arcturus Therapeutics Holdings

Should I short Arcturus Therapeutics Holdings stock?

* Arcturus Therapeutics Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.